NCT01525004 - Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

December 31, 2012

Conditions

Pediatric Solid Organ Transplant Patients

Interventions

DRUG

High-Dose trivalent inactivated influenza vaccine

0.5 mL of high-dose trivalent inactivated influenza vaccine, either one dose or 2 based on whether the patient has previously received standard dose trivalent inactivated influenza vaccine.

DRUG

Standard dose trivalent inactivated influenza vaccine

0.5 mL standard dose trivalent inactivated influenza vaccine, either one dose or 2 based on whether the patient has previously received standard dose trivalent inactivated influenza vaccine

Trial Locations (1)

37232

Monroe Carell Jr. Children's Hospital at Vanderbilt University, Nashville